Late-life Depression: Evidence-based Treatment and Promising New Directions for Research and Clinical Practice

Psychiatric Clinics of North America

Volumn 34, Issue 2, 2011, Pages 335-355

  Andreescu, Carmen ^a   Reynolds, Charles F ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Late life depression; Novel treatment modalities; Treatment algorithms

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; DONEPEZIL; ESCITALOPRAM; FLUOXETINE; LAMOTRIGINE; LITHIUM; MIANSERIN; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NIMODIPINE; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PERPHENAZINE; PLACEBO; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIANEPTINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADJUVANT THERAPY; ALZHEIMER DISEASE; ANXIETY; BIPOLAR DEPRESSION; BRAIN DEPTH STIMULATION; COGNITIVE DEFECT; COMORBIDITY; DELIRIUM; DEPRESSION; DEPRESSIVE PSYCHOSIS; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; ELDERLY CARE; ELECTROCONVULSIVE THERAPY; GASTROINTESTINAL SYMPTOM; GERONTOPSYCHIATRY; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HUMAN; HYPOTHYROIDISM; LATE LIFE DEPRESSION; MAGNETOTHERAPY; MAINTENANCE THERAPY; MAJOR DEPRESSION; MEDICAL DECISION MAKING; MELANCHOLIA; MENTAL DISEASE; MILD COGNITIVE IMPAIRMENT; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; ONSET AGE; PHARMACOGENETICS; POLYURIA; PRIORITY JOURNAL; PROGNOSIS; PSYCHOTHERAPY; RECURRENT DISEASE; REVIEW; RISK FACTOR; SICK SINUS SYNDROME; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VAGUS NERVE STIMULATION; VASCULAR DEPRESSION;

AGED; AGED, 80 AND OVER; AGING; DEPRESSIVE DISORDER; DRUG THERAPY; ELECTROCONVULSIVE THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SUICIDE; TREATMENT OUTCOME;

EID: 79955373187     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2011.02.005     Document Type: Review

References (110)

1. Moussavi S., Chatterji S., Verdes E., et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007, 370:851-858.
2. Alexopoulos G.S., Kelly R.E. Research advances in geriatric depression. World Psychiatry 2009, 8:140-149.
3. Reynolds C.F. The cutting edge: prevention of depressive disorders. Depress Anxiety 2009, 26:1062-1065.
4. Chapman D.P., Perry G.S. Depression as a major component of public health for older adults. Prev Chronic Dis 2008, 5:A22.
5. Bruce M.L., Ten Have T.R., Reynolds C.F., et al. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. J Am Med Assoc 2004, 291:1081-1091.
6. Charney D.S., Reynolds C.F., Lewis L., et al. Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry 2003, 60:664-672.
7. Stevens J.A., Hasbrouck L.M., Durant T.M., et al. Surveillance for injuries and violence among older adults. MMWR CDC Surveill Summ 1999, 48:27-50.
8. Mitchell A.J., Subramaniam H. Prognosis of depression in old age compared to middle age: a systematic review of comparative studies. Am J Psychiatry 2005, 162:1588-1601.
9. Mottram P., Wilson K., Strobl J. Antidepressants for depressed elderly. Cochrane Database Syst Rev 2006, 1. CD003491.
10. Taylor W.D., Doraiswamy P.M. A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future. Neuropsychopharmacology 2004, 29:2285-2299.
11. Nelson J.C., Clary C.M., Leon A.C., et al. Symptoms of late-life depression: frequency and change during treatment. Am J Geriatr Psychiatry 2005, 13:520-526.
12. Kozel F.A., Trivedi M.H., Wisniewski S.R., et al. Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report. Am J Geriatr Psychiatry 2008, 16:58-64.
13. McGrath P.J., Khan A.Y., Trivedi M.H., et al. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. J Clin Psychiatry 2008, 69:1847-1855.
14. Alexopoulos G.S., Katz I.R., Reynolds C.F., et al. Pharmacotherapy of depression in older patients: a summary of the expert consensus guidelines. J Psychiatr Pract 2001, 7:361-376.
15. Zis A.P., Grof P., Webster M. Predictors of relapse in recurrent affective disorders. Psychopharmacol Bull 1980, 16:47-49.
16. Reynolds C.F., Dew M.A., Pollock B.G., et al. Maintenance treatment of major depression in old age. N Engl J Med 2006, 354:1130-1138.
17. Reynolds C.F., Frank E., Perel J.M., et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. J Am Med Assoc 1999, 281:39-45.
18. Klysner R., Bent-Hansen J., Hansen H.L., et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy. Br J Psychiatry 2002, 19:29-35.
19. Wilson K.C., Mottram P.G., Ashworth L., et al. Older community residents with depression: long-term treatment with sertraline. Randomised, double-blind, placebo-controlled study. Br J Psychiatry 2003, 182:492-497.
20. Wilson K.C., Mottram P.G., Vassilas C.A. Psychotherapeutic treatments for older depressed people. Cochrane Database Syst Rev 2008, 1. CD004853.
21. Grant R.W., Casey D.A. Adapting cognitive behavioral therapy for the frail elderly. Int Psychogeriatr 1995, 7:561-571.
22. Butters M.A., Whyte E.M., Nebes R.D., et al. The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry 2004, 61:587-595.
23. Alexopoulos G.S., Raue P., Arean P.A. Problem-solving therapy versus supportive therapy in geriatric major depression with executive dysfunction. Am J Geriatr Psychiatry 2003, 11:46-52.
24. Alexopoulos G.S., Raue P.J., Kanellopoulos D., et al. Problem-solving therapy for the depression-executive dysfunction syndrome of late life. Int J Geriatr Psychiatry 2008, 23:782-788.
25. Arean P.A., Perri M.G., Nezu A.M., et al. Comparative effectiveness of social problem-solving therapy and reminiscence therapy as treatments for depression in older adults. J Consult Clin Psychol 1993, 61:1003-1010.
26. Serfaty M.A., Haworth D., Blanchard M., et al. Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care: a randomized controlled trial. Arch Gen Psychiatry 2009, 66:1332-1340.
27. Arean P.A., Raue P., Mackin R.S., et al. Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction. Am J Psychiatry 2010, 167:1391-1398.
28. Pinquart M., Duberstein P.R., Lyness J.M. Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy. Am J Psychiatry 2006, 163:1493-1501.
29. Flint A.J., Rifat S.L. The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT. Int J Geriatr Psychiatry 1998, 13:23-28.
30. Rice E.H., Sombrotto L.B., Markowitz J.C., et al. Cardiovascular morbidity in high-risk patients during ECT. Am J Psychiatry 1994, 151:1637-1641.
31. van der Wurff F.B., Stek M.L., Hoogendijk W.L., et al. Electroconvulsive therapy for the depressed elderly. Cochrane Database Syst Rev 2003, 2. CD003593.
32. Driscoll H.C., Karp J.F., Dew M.A., et al. Getting better, getting well: understanding and managing partial and non-response to pharmacological treatment of non-psychotic major depression in old age. Drugs Aging 2007, 24:801-814.
33. Mulsant B.H., Pollock B. Treatment-resistant depression in late-life. J Geriatr Psychiatry Neurol 1998, 11:186-193.
34. Flint A.J. Treatment-resistant depression in late life. CNS Spectr 2002, 7:733-738.
35. Shelton R.C., Osuntokun O., Heinloth A.N., et al. Therapeutic options for treatment-resistant depression. CNS Drugs 2010, 24:131-161.
36. Kok R.M., Nolen W.A., Heeren T.J. Outcome of late-life depression after 3 years of sequential treatment. Acta Psychiatr Scand 2009, 119:274-281.
37. Sheffrin M., Driscoll H.C., Lenze E.J., et al. Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission. J Clin Psychiatry 2009, 70:208-213.
38. Lavretsky H., Park S., Siddarth P., et al. Methylphenidate-enhanced antidepressant response to citalopram in the elderly: a double-blind placebo-controlled pilot trial. Am J Geriatr Psychiatry 2006, 14:181-185.
39. Schmidt do Prado-Lima P.A., Bacaltchuck J. Topiramate in treatment-resistant depression and binge-eating disorder. Bipolar Disord 2002, 4:271-273.
40. Thomas S.P., Nandhra H.S., Jayaraman A. Systematic review of lamotrigine augmentation of treatment resistant unipolar depression (TRD). J Ment Health 2010, 19:168-175.
41. Dew M.A., Whyte E.M., Lenze E.J., et al. Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. Am J Psychiatry 2007, 164:892-899.
42. Reynolds C.F., Dew M.A., Martire L.M., et al. Treating depression to remission in older adults: a controlled evaluation of combined interpersonal psychotherapy versus escitalopram with depression care management. Int J Geriatr Psychiatry 2010, 25:1134-1141.
43. Lenze E.J. Comorbidity of depression and anxiety in the elderly. Curr Psychiatry Rep 2003, 5:62-67.
44. Beekman A.T., de Beurs E., van Balkom A.J., et al. Anxiety and depression in later life: co-occurrence and communality of risk factors. Am J Psychiatry 2000, 157:89-95.
45. Andreescu C., Lenze E.J., Dew M.A., et al. Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. Br J Psychiatry 2007, 190:344-349.
46. Greenlee A., Karp J.F., Dew M.A., et al. Anxiety impairs depression remission in partial responders during extended treatment in late-life. Depress Anxiety 2010, 27:451-456.
47. Andreescu C., Lenze E., Mulsant B., et al. High worry severity is associated with poorer acute and maintenance efficacy of antidepressants in late-life depression. Depress Anxiety 2009, 26:266-272.
48. Coryell W., Leon A., Winokur G., et al. Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry 1996, 153:483-489.
49. Maj M., Pirozzi R., Magliano L., et al. Phenomenology and prognostic significance of delusions in major depressive disorder: a 10-year prospective follow-up study. J Clin Psychiatry 2007, 68:1411-1417.
50. Vythilingam M., Chen J., Bremner J.D., et al. Psychotic depression and mortality. Am J Psychiatry 2003, 160:574-576.
51. Mulsant B.H., Pollock B.G., Nebes R., et al. A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients. Am J Geriatr Psychiatry 2001, 9:406-414.
52. Andreescu C., Mulsant B.H., Rothschild A.J., et al. Pharmacotherapy of major depression with psychotic features: what is the evidence?. Psychiatr Ann 2006, 36:31-38.
53. Meyers B.S., Flint A.J., Rothschild A.J., et al. A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Arch Gen Psychiatry 2009, 66:838-847.
54. Andreescu C., Mulsant B.H., Peasley-Miklus C., et al. Persisting low use of antipsychotic in the treatment of major depression with psychotic features. J Clin Psychiatry 2007, 68:194-200.
55. Sackeim H.A., Haskett R.F., Mulsant B.H., et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy. J Am Med Assoc 2001, 285:1299-1307.
56. Sheline Y.I., Pieper C.F., Barch D.M., et al. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry 2010, 67:277-285.
57. Hickie I., Scott E., Mitchell P., et al. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 1995, 37:151-160.
58. Simpson S., Baldwin R.C., Jackson A., et al. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol Med 1998, 28:1015-1026.
59. Salloway S., Boyle P.A., Correia S., et al. The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients. Am J Geriatr Psychiatry 2002, 10:107-111.
60. Ramasubbu R., Goodyear B.G. Methylphenidate modulates activity within cognitive neural networks of patients with post-stroke major depression: a placebo-controlled fMRI study. Neuropsychiatr Dis Treat 2008, 4:1251-1266.
61. Taragano F.E., Allegri R., Vicario A., et al. A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of 'vascular depression'. Int J Geriatr Psychiatry 2001, 16:254-260.
62. Taragano F.E., Bagnatti P., Allegri R.F. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of " vascular depression" Int Psychogeriatr 2005, 17:487-498.
63. Reynolds C.F., Butters M.A., Lopez O., et al. Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Arch Gen Psychiatry 2011, 68(1):51-60.
64. Lyketsos C.G., DelCampo L., Steinberg M., et al. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Arch Gen Psychiatry 2003, 60:737-746.
65. Roth M., Mountjoy C.Q., Amrein R. Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial. Br J Psychiatry 1996, 168:149-157.
66. Nyth A.L., Gottfries C.G., Lyby K., et al. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatr Scand 1992, 86:138-145.
67. Petracca G., Teson A., Chemerinski E., et al. A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1996, 8:270-275.
68. Weintraub D., Rosenberg P.B., Drye L.T., et al. Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. Am J Geriatr Psychiatry 2010, 18:332-340.
69. Karlsson I., Godderis J., Augusto De Mendonca Lima C., et al. A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia. Int J Geriatr Psychiatry 2000, 15:295-305.
70. Young R.C., Gyulai L., Mulsant B.H., et al. Pharmacotherapy of bipolar disorder in old age: review and recommendations. Am J Geriatr Psychiatry 2004, 12:342-357.
71. Sajatovic M., Gyulai L., Calabrese J.R., et al. Maintenance treatment outcomes in older patients with bipolar I disorder. Am J Geriatr Psychiatry 2005, 13:305-311.
72. Nemeroff C.B. Advancing the treatment of mood and anxiety disorders: the first 10 years' experience with paroxetine. Psychopharmacol Bull 2003, 37(Suppl 1):6-7.
73. Smith R.E., Helms P.M. Adverse effects of lithium therapy in the acutely ill elderly patient. J Clin Psychiatry 1982, 43:94-99.
74. Whyte E.M., Dew M.A., Gildengers A., et al. Time course of response to antidepressants in late-life major depression: therapeutic implications. Drugs Aging 2004, 21:531-554.
75. Andreescu C., Mulsant B.H., Houck P.R., et al. Empirically derived decision trees for the treatment of late-life depression. Am J Psychiatry 2008, 165:855-862.
76. Kiernan M., Kraemer H.C., Winkleby M.A., et al. Do logistic regression and signal detection identify different subgroups at risk? Implications for the design of tailored interventions. Psychol Methods 2001, 6:35-48.
77. Oquendo M.A., Baca-Garcia E., Kartachov A., et al. A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression. J Clin Psychiatry 2003, 64:825-833.
78. Dew M.A., Reynolds C.F., Houck P.R., et al. Temporal profiles of the course of depression during treatment: predictors of pathways toward recovery in the elderly. Arch Gen Psychiatry 1997, 54:1016-1024.
79. Dew M.A., Reynolds C.F., Mulsant B., et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. J Affect Disord 2001, 65:155-166.
80. Jorge R.E., Moser D.J., Acion L., et al. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry 2008, 65:268-276.
81. Narushima K., McCormick L.M., Yamada T., et al. Subgenual cingulate theta activity predicts treatment response of repetitive transcranial magnetic stimulation in participants with vascular depression. J Neuropsychiatry Clin Neurosci 2010, 22:75-84.
82. Mayberg H.S., Lozano A.M., Voon V., et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660.
83. Malone D.A., Dougherty D.D., Rezai A.R., et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 2009, 65:267-275.
84. Nemeroff C.B., Mayberg H.S., Krahl S.E., et al. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 2006, 31:1345-1355.
85. MacQueen G.M. Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder. J Psychiatry Neurosci 2009, 34:343-349.
86. Mayberg H.S., Brannan S.K., Tekell J.L., et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000, 48:830-843.
87. Gunning-Dixon F.M., Walton M., Cheng J., et al. MRI signal hyperintensities and treatment remission of geriatric depression. J Affect Disord 2010, 126(3):395-401.
88. Taylor W.D., Kuchibhatla M., Payne M.E., et al. Frontal white matter anisotropy and antidepressant remission in late-life depression. PLoS One 2008, 3:e3267.
89. Malhotra A.K. The pharmacogenetics of depression: enter the GWAS. Am J Psychiatry 2010, 167:493-495.
90. Serretti A., Kato M., RonchiDe D., et al. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 2007, 12:247-257.
91. Gerretsen P., Pollock B.G. Pharmacogenetics and the serotonin transporter in late-life depression. Expert Opin Drug Metab Toxicol 2008, 4:1465-1478.
92. MacLeod C., Mathews A., Tata P. Attentional bias in emotional disorders. J Abnorm Psychol 1986, 95:15-20.
93. Garriock H.A., Tanowitz M., Kraft J.B., et al. Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder. Am J Psychiatry 2010, 167:565-573.
94. Uher R., Perroud N., Ng M.Y., et al. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry 2010, 167:555-564.
95. Guidi J., Fava G.A., Fava M., et al. Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis. Psychol Med 2011, 41(2):321-331.
96. Yildiz A., Mantar A., Simsek S., et al. Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse: a pilot controlled trial. J ECT 2010, 26:104-110.
97. Robinson R.G., Tenev V., Jorge R.E. Citalopram for continuation therapy after repetitive transcranial magnetic stimulation in vascular depression. Am J Geriatr Psychiatry 2009, 17:682-687.
98. Almeida O.P., McCaul K., Hankey G.J., et al. Homocysteine and depression in later life. Arch Gen Psychiatry 2008, 65:1286-1294.
99. Alexopoulos G.S., Katz I.R., Bruce M.L., et al. Remission in depressed geriatric primary care patients: a report from the PROSPECT study. Am J Psychiatry 2005, 162:718-724.
100. Unutzer J., Katon W., Callahan C.M., et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. J Am Med Assoc 2002, 288:2836-2845.
101. Snowden M., Steinman L., Frederick J. Treating depression in older adults: challenges to implementing the recommendations of an expert panel. Prev Chronic Dis 2008, 5:A26.
102. Reynolds C.F., Hoch C.C., Buysse D.J., et al. Sleep in late-life recurrent depression: changes during early continuation therapy with nortriptyline. Neuropsychopharmacology 1991, 5:85-96.
103. Smith G.S., Reynolds C.F., Pollock B., et al. Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression. Am J Psychiatry 1999, 156:683-689.
104. Mulsant B.H., Houck P.R., Gildengers A.G., et al. What is the optimal duration of a short-term antidepressant trial when treating geriatric depression?. J Clin Psychopharmacol 2006, 26:113-120.
105. Gildengers A.G., Houck P.R., Mulsant B.H., et al. Trajectories of treatment response in late-life depression: psychosocial and clinical correlates. J Clin Psychopharmacol 2005, 25:S8-S13.
106. Szanto K., Mulsant B.H., Houck P., et al. Occurrence and course of suicidality during short-term treatment of late-life depression. Arch Gen Psychiatry 2003, 60:610-617.
107. Tew J.D., Mulsant B.H., Houck P.R., et al. Impact of prior inadequate treatment exposure on response to antidepressant treatment in late life. Am J Geriatr Psychiatry 2006, 14:957-965.
108. Martire L.M., Schulz R., Reynolds C.F., et al. Impact of close family members on older adults' early response to depression treatment. Psychol Aging 2008, 23:447-452.
109. Cohen A., Houck P.R., Szanto K., et al. Social inequalities in response to antidepressant treatment in older adults. Arch Gen Psychiatry 2006, 63:50-56.
110. Lotrich F.E., Pollock B.G., Kirshner M., et al. Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients. J Psychiatry Neurosci 2008, 33(2):123-130.